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Multiple lines of evidence suggest that disturbances in excitatory transmission contribute to depression. Whether these defects involve
the number, size, or composition of glutamatergic contacts is unclear. This study used recently introduced procedures for fluorescence
deconvolution tomography in a well-studied rat model of congenital depression to characterize excitatory synapses in layer I of infra-
limbic cortex, a region involved in mood disorders, and of primary somatosensory cortex. Three groups were studied: (1) rats bred for
learned helplessness (cLH); (2) rats resistant to learned helplessness (cNLH); and (3) control Sprague Dawley rats. In fields within
infralimbic cortex, cLH rats had the same numerical density of synapses, immunolabeled for either the postsynaptic density (PSD)
marker PSD95 or the presynaptic protein synaptophysin, as controls. However, PSD95 immunolabeling intensities were substantially
lower in cLHrats, aswerenumerical densities of synapse-sized clusters of theAMPAreceptor subunitGluA1. Similar but less pronounced
differences (comparable numerical densities but reduced immunolabeling intensity for PSD95)were found in the somatosensory cortex.
In contrast, non-helpless rats had25%morePSDs than either cLHor control ratswithout any increase in synaptophysin-labeled terminal
frequency. Compared with controls, both cLH and cNLH rats had fewer GABAergic contacts. These results indicate that congenital
tendencies that increase or decrease depression-like behavior differentially affect excitatory synapses.
Introduction
Major depressive disorder (MDD) affects 16% of the population,
with notable costs to patients and society (Kessler et al., 2003).
Although the biogenic amine theory has had considerable success
(Delgado, 2000; Hirschfeld, 2000), depression is now recognized
to be associated with many disturbances (Castre´n et al., 2007;
Luscher et al., 2011; Samuels and Hen, 2011; Sanacora et al.,
2012). Abnormalities in glutamatergic transmission have re-
ceived considerable attention. Glutamate levels are altered in
brains of patients (Sanacora et al., 2004; Yu¨ksel andOngu¨r, 2010)
and rodent models (Hascup et al., 2011; Schulz et al., 2013).
Several drugs that affect excitatory synapses have positive effects
(Sanacora et al., 2012). Ketamine, which inhibits NMDA-type
glutamate receptors, has rapid antidepressant actions (Machado-
Vieira et al., 2009; Bunney and Bunney, 2012). Positive allosteric
modulators of AMPA-type glutamate receptors also decrease
depressive-like behavior in animal models (Bai et al., 2001; Li et
al., 2001) and enhance the potency of monoamine-based antide-
pressants (Li et al., 2003).
In additional support of the “glutamate hypothesis,” dendritic
spine density is decreased in hippocampus in acute models of
depression (Norrholm and Ouimet, 2001; Hajszan et al., 2009).
Similar effects are seen in cortex of chronically stressed rats (Du-
man and Aghajanian, 2012), but it is not known whether spine
counts are decreased in cortical regions associated with depres-
sion. A recent postmortem study found that levels markers (syn-
aptophysin, debrin) for glutamatergic contacts are reduced in
frontal cortex samples from patients with bipolar disorder (Kim
et al., 2010). Similarly, proteins associated with excitatory syn-
apses (PSD95, NR2A, and NR2B) are decreased in homogenates
from prefrontal cortex of MDD subjects (Feyissa et al., 2009).
Although neither study analyzed synapses, their results suggest
that excitatory connections may be reduced in size or decreased
in numbers in cortex in association with chronic depression.
The present studies used a recently introduced technology,
fluorescence deconvolution tomography, to investigate the above
possibilities in a well-characterized model of congenital depres-
sion. These methods, which measure large numbers of synapses
within 3D reconstructions of sample fields, have been used to test
for effects of experimental manipulations on synapse numbers,
volumes, and immunolabeling intensities in hippocampus (Rex
et al., 2009; Seese et al., 2012). The present study is a first use of
this approach to determine whether these synapse measures dif-
fer in rodents exhibiting behavioral phenotypes related to affec-
tive disorders. Specifically, we evaluated synapses in layer I of
infralimbic cortex in rat lines bred over 50 generations to express
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learned helplessness (cLH) or non-helplessness (cNLH) (Schulz
et al., 2010). This area is homologous to Brodmann area 25 in
humans (Ongu¨r et al., 2003), a region implicated in affective
disorders, including depression (Drevets et al., 1997, 2002; May-
berg et al., 1999, 2005; Hajek et al., 2008). Along with behavior
that suggests anhedonia (Vollmayr et al., 2004) and a delayed
response to antidepressants (Patel et al., 2004), the cLH rats have
abnormal glutamate levels (Schulz et al., 2013), altered glutamate
metabolism (Shumake et al., 2000), reduced expression of spe-
cific excitatory amino acid transporters (Zink et al., 2010), and
decreased levels of proteins implicated in excitatory synaptic re-
lease (Zink et al., 2007). Thus, the cLH phenotype is particularly
appropriate for testing the prediction that chronic depression is
associated with significant changes to cortical glutamatergic
synapses.
Materials andMethods
Animals and learned helplessness. Adult rats were bred over 50 genera-
tions for expression of congenital learned helpless or non-helpless behav-
ior (Schulz et al., 2010); we used 12- to 18-week-old male rats from our
breeding colony (Schulz et al., 2010). Age-matchedmale SpragueDawley
control rats, supplied by Taconic Farms and housed with the cLH and
cNLH lines for at least 2 weeks, were also used. All procedures were
approved by the Institutional Animal Care and Use Committees and
were conducted in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
All cLH and cNLH rats underwent learned helplessness training and
testing (Schulz et al., 2010). Skinner boxes with grid floors were used to
deliver 120 uncontrollable 5- to 15-s-long footshocks at 0.4 mA over a
period of 40min. The next day, rats were tested for helplessness. Each box
was equipped with a lever and a signal light; the latter turned on and off
with the footshock. Fifteen footshocks were delivered, each lasting 60 s
unless turned off earlier by lever press. Lever presses were automatically
recorded by Graphic State (Coulbourn Instruments). The number of
lever presses that turned off the footshock within 20 and 60 s of shock
onset and the time to complete the 15 trials were recorded. Animals were
considered cLHwhen they turned off the footshock on nomore than five
trials and cNLH when they pressed the lever at least eight times within
20 s of shock onset. At least 24 h after this testing, rats were deeply
anesthetized with isoflurane gas and decapitated. Brains were rapidly
removed, frozen in45°C isopentane, and stored at80°C until use.
Tissue preparation and immunohistochemistry.Using anatomical land-
marks, brains of cLH, cNLH, and age-matched (12–18 week) Sprague
Dawley control rats (Schulz et al., 2010) were sectioned using a calibrated
cryostat (coronal, 20 m, 20°C) into a library containing multiple
series of equally spaced sections spanning the rostrocaudal extent of
primary somatosensory forelimb (parietal) neocortex and infralimbic
cortex; tissue was fixed in20°Cmethanol for 15min. The rostrocaudal
extent of infralimbic cortex is 1.5 mm, and we sampled 1.2 mm of
this length using at least four coronal sections separated by 0.3 mm. The
positioning of the first section of the series as well as the dorsoventral
orientation of sections varied (e.g., from trimming and positioning of the
tissue block). Accordingly, results described here should not be consid-
ered as coming from precisely matched sections but rather from a series
of evenly spaced sample planes located in a quasi-randommanner along
80%of the infralimbic anteroposterior dimension. Although it was not
our intention to create this unstructured variability in locations, modern
stereological theory has described advantages of quasi-random sampling
for estimating sizes and frequencies of cortical elements (for review, see
Dorph-Petersen and Lewis, 2011).
A tissue series was selected at random and then processed for immu-
nofluorescence. The diluent used for primary and secondary antisera
consisted of 0.1 M phosphate buffer containing 4% BSA and 0.3% Triton
X-100 (Seese et al., 2012). Sectionswere incubated in primary antisera for
24 h at room temperature using goat anti-GluA1 (1:100; catalog #sc-
7609; Santa Cruz Biotechnology) or mouse antisera to PSD95 (1:1000;
catalog #1-1054; Thermo Fisher Scientific), synaptophysin (1:1000; cat-
alog #S5768; Sigma-Aldrich), or the GABAA receptor (GABAAR)  sub-
unit (1:200; catalog #MAB341; Millipore). Alexa Fluor 488 goat anti-
mouse or donkey anti-goat IgG (1:1000; Invitrogen) were used as
secondary antisera. Sections were coverslipped with VectaShield includ-
ing DAPI (catalog #H-1200; Vector Laboratories). Sections from all an-
imals of the three experimental groups were processed together for
immunohistochemistry and image analysis.
Fluorescence deconvolution tomography.Using a Leica DM6000 epiflu-
orescence microscope, a 63 oil-immersion objective (numerical aper-
ture 1.4) and an ORCA-ER (Hamamatsu) camera, digital image z-stacks
were collected through 3 m (0.2 m steps) for 136  105 m sample
fields that were centered on layer I of infralimbic or parietal cortex. Layer
I was selected for analysis because of the relative paucity of neuronal cell
bodies. Images were systematically collected from evenly spaced sections
approximately positioned from 3.72 to 2.52 mm anterior to bregma for
infralimbic cortex and from 2.52 to 2.04 mm anterior to bregma for
somatosensory cortex (Paxinos and Watson, 2007). An experimenter
confirmed full penetration of immunolabeling through the entire sam-
pled 3 m depth. For each region and section, one or two z-stacks were
collected from the target field. z-Stacks were processed for restorative
deconvolution (Volocity 5.0; PerkinElmer Life and Analytical Sciences),
and in-house software was used to normalize background fluorescence
intensity and construct 3D montages of each 42,840 m3 sample field.
Automated systems were then used to count and measure 3D volumes
and fluorescence intensities of immunolabeled elements (Rex et al., 2009;
Seese et al., 2012). This automated image analysis only quantified objects
that satisfied the size and eccentricity constraints of synapses, that were
present in multiple density thresholds, and whose boundaries were fully
contained within the z-stack, similar to the associated point count rule
used in stereological techniques (Moyer et al., 2012). Objects detected by
only one threshold, and thus likely to be immunostaining artifacts, were
excluded from quantification.
Statistical analyses. Statistical significance (p 0.05) was assessed us-
ing ANOVAwith planned post hoc comparisons, the two-tailed Student’s
t test, the  2 test, or linear regression analysis. For both cortical fields,
measures were collected from at least eight z-stacks, across at least four
tissue sections, per brain. Counts of immunopositive () elements
within each z-stack were averaged for each region and brain. A single n
was considered to be a separate animal for all analyses. In analyses of
immunolabeled volumes and intensities, the frequency distributions of
labeled elements were plotted across 0.001 m3 and 5 unit bins, respec-
tively, and divided by the total number of sections imaged.
Results
PSD95 immunolabeling is homogeneously distributed within
infralimbic cortex layer I
Data were collected from the two outbred lines (Schulz et al.,
2010) and from unrelated Sprague Dawley control rats, the latter
to identify effects of selective breeding that do not relate to help-
lessness. Tissue sections were processed for immunofluorescence
localization of PSD95, a protein that is distributed evenly across
excitatory PSDs (Aoki et al., 2001; Megías et al., 2001). Images of
a 136 105 3 m field were collected from layer I within the
cytoarchitectonic boundaries of infralimbic cortex, the rat ho-
molog of Brodmann area 25 (Ongu¨r et al., 2003). Two contiguous
zones were sampled for each section. As noted, these sections
were not positioned at precisely the same planes along the antero-
posterior dimension of the target cortex. The resultant sample
covered 50% of the depth (mediolateral axis) and 20% of the
height (dorsoventral axis) of infralimbic cortex layer I within
sections analyzed. We do not assume that the results described
here necessarily apply to the remainder of the layer. Image
z-stacks underwent restorative deconvolution, followed by 3D
reconstructions from the contiguous optical planes; numbers,
volumes, and immunolabeling intensities of synaptic elements
fully contained within the sample fields were then quantified
using automated systems (Rex et al., 2009; Seese et al., 2012).
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Approximately 250,000 synapses were individually analyzed for
infralimbic cortex for each rat. It is important to note that the
thickness of infralimbic cortex layer I did not differ for the three
groups of rats (control, 289 9 m; cNLH, 283 11 m; cLH,
279 14 m).
We first tested whether PSD95 labeling was evenly distributed
throughout the sampling fields by subdividing each field into 10
m segments parallel to the dorsoventral axis. Averaging the val-
ues across all rats in a group reduced the variance for individual
segments and thus increased the sensitivity of the test for regional
heterogeneity. For each group, the percentage of the total PSD95-
immunoreactive (IR) elements of the field present in each seg-
ment varied little across the dorsoventral axis (Fig. 1A; control,
9.86  0.08%; cLH, 9.86  0.10%; cNLH, 9.85  0.08%). A 2
test of this analysis confirmed that the observed values did not
differ significantly from what would be expected from a homo-
geneous population (control, 2  0.18, df  9, p  0.90; cLH,
2 0.21, df 9, p 0.90; cNLH, 2 0.08, df 9, p 0.90).
Repeating these exercises by subdividing each sample field dor-
soventrally into 10m segments along themediolateral axis pro-
duced similar results (control, 7.48 0.05%, 2 0.08, df 12,
p 0.90; cLH, 7.49 0.06%,2 0.12, df 12, p 0.90; cNLH,
7.49  0.05%, 2  0.08, df  12, p  0.90). To address the
possibility that positive and negative slopes occur across animals
because of individual differences, and thus cancel out dimen-
sional effects in group averages, we calculated means and SDs for
absolute slopes of each image. This produced the following re-
sults for x-axis (control, 0.74  0.58; cLH, 1.44  1.10; cNLH,
1.01 1.24) and y-axis (control, 1.78 1.20; cLH, 1.92 1.30;
cNLH, 1.51 1.76); in these measures, a slope of 1 represents a
variation of 10 synapses per 10 m segment, which represents
0.004% of the total synapses surveyed per image. Regression
analyses indicate that none of these values approaches statistical
significance (R2 0.28 and p 0.11 for all cases).
The above parametric tests for regional differencesmightmiss
gradients in the numerical density of immunostaining along one
or more of the three axes. We tested for directionality by calcu-
lating the gradient in all directions of each image. As depicted in
Figure 1B, each sample field was divided into 1000 blocks (10 in
each axis), and then object numerical densities of every other
single block were subtracted from its neighbor. These differences
were then summed to give the total directionality along each axis.
This is represented in Equations 1–3, where M is the matrix of
PSD95-IR element numerical density, andx,y, andz are the
calculated gradients along each axis:
x  2 i1n k1n j1n/ 2 	Mi	2j1
k  Mi2jk
,
y  2 j1n k1n i1n/ 2 	M	2i1
 jk  M2ijk
,
z  2 i1n j1n k1n/ 2 	Mij	2k1
  Mij2k
.
The calculations confirmed that the numerical density direction-
ality in all sample fields surveyed is 214 467 (mean SD) in the
positive x direction, 70.2  441 in the positive y direction, and
508 1218 in the positive z direction. These mean values repre-
sented 0.8, 0.03, and 1.9% of the total synapses quantified.
ANOVA confirmed a lack of interaction between rat strain and
directionality in the x and y directions (p  0.30 for both). A
modest interaction between strain and measures in the z plane
was present (p  0.05). Additional analyses confirmed that this
effect was secondary to small differences unlikely to influence the
large synaptic populations quantified. In particular, control ani-
mals exhibited 2.0 and 1.2% more synapses at the top of their
z-stacks than at their bottoms compared with cLH and cNLH
animals, respectively. We tested whether these differences af-
fected synaptic measurements through the anteroposterior axis
of infralimbic cortex by calculating the difference of PSD95
object numerical densities between the most rostral and caudal
sections sampled. ANOVA confirmed no effect of group on these
anteroposterior differences (p 0.95). We conclude from these
analyses that staining variations are distributed homogeneously
across the subzone of infralimbic cortex examined. It remains
possible that regional variation exists in infralimbic fields not
included in the study.
PSD95 immunofluorescence intensity is lower in infralimbic
cortex of cLH rats
The numerical density of synapse-sized PSD95 clusters in
infralimbic sample fields (Fig. 2A–C) varied little between
control rats and was nearly identical to cLH counts (23,750
864 vs 23,339  860 per 136  105  3 m sampling zone),
indicating that the cLH phenotype does not arise from a loss of
excitatory synapses. Frequency distribution curves for sizes of
PSD95 synapses in control and cLH
rats had a strong positive skew, but the
cLH group had fewer large contacts
(Fig. 2D,E). This resulted in signifi-
cantly lower median volumes for
PSD95 elements in cLH rats (control,
0.040 0.001 m3; cLH, 0.033 0.001
m3; p  0.004). The difference be-
tween groups was more striking for
PSD95 immunolabeling intensity: the
PSD95 object intensity frequency dis-
tribution was strongly left shifted in
cLH rats relative to controls (Fig. 2F ).
As such, median fluorescence intensity
values were markedly lower in cLH rats
(control, 108.1  1.4 units; cLH,
100.5  0.8 units; p  0.00007). We
evaluated the shape of the cumulative
probability curves for intensity distribu-
tions for individual rats (Fig. 2G) using
the Boltzmann sigmoidal fit and then
Figure 1. PSD95-IR clusters are evenly distributed across infralimbic fields quantified by fluorescence deconvolution tomogra-
phy. A, Top, Each sample field surveyedwas dividedmediolaterally into 10mdorsoventral segments and dorsoventrally into 10
mmediolateral segments. Plot shows percentage of total PSD95-IR elementswithin each 10msegment for control (con), cLH,
and cNLH rats. The absolute percentage is greater in the ydimension than the xbecause the latter containsmore 10msegments.
Note the small variability within each segment (error bars are occluded by data points); values are not significantly different from
what would be expected from a homogeneous sample field ( p 0.90 for both dimensions). B, Representative heat maps of
PSD95 object numerical densities across the x- and y-axes of the sampled field for control, cLH, and cNLH groups. Color denotes
the incidence of immunolabeled elements per 10.5 13.6m block, as indicated by the scale on the right. The variation across
the sample field was found to be relatively small with no clear gradients in any dimension.
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compared the means for each group to test the reliability of the
curve shift in Figure 2F. The difference between cLH and con-
trol groups was highly significant (p 0.0007). These analyses
suggest that, within the synapse-sized immunolabeled ele-
ments, concentrations of PSD95 are markedly reduced in cLH
rats relative to controls.
We confirmed that the loss of PSD95 immunoreactivity was
not influenced by differences in synapse volumes by comparing
the immunolabeling intensities of contacts across 90% of the
volume distribution described in Figure 2D (i.e., minus the right-
hand tail of the distribution). The leftward shift in labeling inten-
sities for cLH rats found when evaluating the entire population
was also evident when restricting analysis to contacts with the
same mean volumes in the two groups; as such, median labeling
intensity values were still significantly less in the cLH group after
eliminating the largest 10% of the contacts (control, 105.8 0.9
units; cLH, 99.6  0.7 units; p  0.00004). We conclude that,
relative to controls, the major synaptic correlate of the cLH phe-
notype is a reduction in the synaptic concentration of PSD95.
Numbers of GluA1 elements are lower in cLH rats
Reductions in PSD95 immunolabeling intensities in cLH rats
raise the question of whether there were also changes in synapse-
sized clusters of AMPA receptors. We tested this using immuno-
staining for the GluA1 subunit of the receptor in sample fields
from infralimbic cortex of control and cLH rats. Possibly related
to the loss of PSD95 immunofluorescence intensity, mean
GluA1 element counts for the cLH group were reduced by
25% relative to values from controls (p 0.008; Fig. 3A). The
losses were not secondary to a reduction in the mean size or
immunofluorescence intensity of GluA1 clusters, because these
values were not different between groups: 0.018  0.001 versus
0.018 0.001 m3 for volume and 94.6 0.4 versus 93.5 0.5
units for fluorescence intensity for control and cLH rats, respec-
tively. As anticipated from these results, the loss of GluA1 ele-
ments occurred across the full range of labeling intensities (Fig.
3B). These results add a second correlate to the cLH phenotype: a
loss of GluA1-containing AMPA receptors from a significant
population of excitatory synapses.
Numbers of PSD95 synapses are elevated in infralimbic
cortex of cNLH rats
We also tested a group of rats bred to be resistant to learned
helplessness (cNLH). In marked contrast to cLH measurements,
the numerical density of PSD95 contacts was30% greater in
infralimbic sample fields from cNLH rats compared with con-
trols (Fig. 4A). ANOVA confirmed that differences between
cNLH, cLH, and control groups were significant (p  0.0001),
with counts from cNLH rats being greater than those from either
cLH or control rats (p  0.001). The frequency distribution of
PSD95 cluster volumes had the same shape in cNLH as in con-
trol rats, but the curve was left shifted in the cNLH group (Fig.
4B), resulting in reduced median volumes (control, 0.038 
Figure 2. Synaptic PSD95 immunoreactivity is reduced in infralimbic cortex in the cLH rat
model of chronic depression. A, Schematic of a coronal section through rostral forebrain iden-
tifying the infralimbic (IL) area ofmedial prefrontal cortex (3mmfrombregma) (Paxinos and
Watson, 2007).B, Nissl-stained section from a control Sprague Dawley rat taken from the same
level as the schematic (scale bar, 500m). The box in the larger image marks the infralimbic
sample field of analysis; inset shows a higher-power image of infralimbic cortex layer I (dashed
box; scale bar, 250m). C, Deconvolved image shows that PSD95 immunoreactivity in infra-
limbic layer I is exclusively localized to discrete clusters that fall within the size range of excit-
atory synapses (scale bar, 2.5 m). D, Frequency distributions of PSD95 synapse sizes in
infralimbic cortex of control Sprague Dawley (blue; n 8) and cLH (green; n 12) rats. E,
Right-most tail of the PSD95 synapse size frequency distributions for control and cLH rats,
showing that the latter group contains fewer very large synapses. F, Frequency distributions of
PSD95 cluster fluorescence intensities for control (blue; n 8) and cLH (green; n 12) rats:
there is a strong leftward shift for cLH rats relative to controls with a significant reduction in
medianvalues ( p0.00007).G, Cumulativeprobability curves formean control (blue) and cLH
(green) PSD95 intensities in infralimbic cortex; comparing the slopes of these curves with a
Boltzmann sigmoidal fit produced a robust statistical difference between cLH and control
groups ( p 0.0007).
Figure 3. Numerical densities of GluA1-containing AMPA receptors are reduced in infralim-
bic fields from cLH rats. A, Bar graph shows that cLH rats (n 12) had25% fewer synapse-
sized clusters of GluA1 immunoreactivity in infralimbic cortex than did control Sprague Dawley
rats (n 8, **p 0.008; values normalized to same-cohort control mean). B, Fluorescence
intensity frequency distributions for GluA1 clusters in control (solid line; n 8) and cLH
(dashed line; n 12) rats illustrate that reductions in GluA1 shown in A occur across all inten-
sities and are not secondary to differences inmean labeling intensity (cLH values normalized to
the mean GluA1 count of the same cohort control group).
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0.0003m3; cNLH, 0.030 0.003m3; p 0.001). As described
above (Fig. 2D), a comparable volume reduction was evident for
PSD95 clusters in cLH infralimbic sample fields, indicating that
the decrease in synapse volume is not related to learned helpless-
ness. Unlike the case for cLH rats, the median immunolabeling
intensity of PSD95 elements was unaffected in cNLH rats (con-
trol, 105.7  1.0 units; cNLH, 105.2  2.0 units; p  0.80).
Moreover, there was no evidence in the cNLH group for the
decrease in the numerical density of synapse-sizedGluA1 clusters
found in the cLH group (p 0.40).
The absence of a clear increase inGluA1 clusters in infralim-
bic cortex of cNLH rats raised the possibility that the greater
numerical densities of PSD95 structures in this layer are not
associatedwith presynaptic elements.We tested this by immuno-
labeling additional sections from the same rats for the transmitter
vesicle protein synaptophysin. Therewere nodifferences between
control and cNLHgroupswith regard to numerical densities (Fig.
4C) or fluorescence intensity distributions (Fig. 4D) of synapto-
physin terminals in infralimbic sample fields.We conclude that
the cNLH phenotype consists of an increase in PSDs lacking pre-
synaptic innervation.
GABAAR
 synapses are unaffected in cLH and cNLH rats
The differences described above for excitatory synapses did not
hold for inhibitory contacts immunolabeled for the GABAAR
(Fig. 5A). In infralimbic fields, total numerical densities of
GABAAR
 elements were reduced in cLH and cNLH groups
compared with controls (Fig. 5B; ANOVA, p  0.03; control vs
cLH, p  0.05). Moreover, median immunolabeling intensities
and sizes of GABAAR
 contacts were not different between the
three groups (Fig. 5C,D). Thus, GABAergic synapses did not ex-
hibit the pattern of changes found for excitatory contacts in either
cLH or cNLH infralimbic cortex.
PSD95 levels are lower in cLH somatosensory cortex
Finally, we performed tests of whether the above-described ef-
fects on PSD95 immunolabeling are distributed across the cortex
by evaluating layer I of primary somatosensory neocortex (Fig.
6A). As found in infralimbic cortex, the mean immunolabeling
intensity of PSD95 clusters was reduced in this parietal field of
cLH rats compared with controls (Fig. 6B): differences in the
Figure 4. Rats bred for resistance to helplessness (cNLH) exhibit elevated numerical densi-
ties of non-innervatedPSDs.A, Bar graph shows that, for sample fieldswithin infralimbic cortex,
the cNLH rats (n 4) have30%more PSD95 clusters than do control rats (n 8, ***p
0.001). B, Frequency distribution of PSD95 element volumes in infralimbic cortex for cNLH
rats (dashed line; n 4)was slightly left shifted comparedwith control rats (solid line; n 8),
resulting in a significant decrease in median volume ( p 0.001). C, D, There were no differ-
ences between control (solid line; n 8) and cNLH (dashed line; n 4) rats in numerical
densities (C) or labeling intensities (D) of synaptophysin elements.
Figure 5. Inhibitory synapse measures were comparable in infralimbic cortical fields from
cLH and cNLH rats.A, Immunolabeling for the GABAAR subunit in infralimbic cortex is limited
to synapse-sized clusters (scale bar, 5m).B, Numerical densities of GABAAR clusterswere less
in infralimbic cortical fields for both cLH (n12) and cNLH (n4) rats comparedwith Sprague
Dawley control rats (n 8). The control versus cLH effect was significant (*p 0.05). C, D,
Comparisons of median GABAAR
 cluster labeling intensities (B) and volumes (C) were not
different between control, cLH, and cNLH rats.
Figure 6. Lower levels of PSD95 are not limited to infralimbic cortex of congenitally de-
pressed rats.A, Top,Nissl-stained section througha control SpragueDawley forebrain, caudal to
that illustrated in Figure 1B, shows the parietal (primary somatosensory forelimb) cortex sam-
pling zone (box) (scale bar, 500m).Bottom,Representativedeconvolved image showsPSD95
immunolabeling in the parietal sample field of a cNLH rat (scale bar, 2.5 m). B, Frequency
distributions of PSD95 cluster intensities in parietal cortex layer I of control (solid line; n 4)
and cLH (dashed line; n 7) rats. Note the leftward shift for cLH compared with control rats,
similar to that observed in infralimbic cortex (see Fig. 2F ).
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median values of the distributions were significant (p  0.05).
Although the percentage decrease in median PSD95 immunola-
beling intensity of cLH rats compared with controls was less in
primary somatosensory neocortex (4.7 1.4%) than in infralim-
bic cortex (7.1 0.07%), this difference was not statistically sig-
nificant (p  0.10). Thus, the loss of PSD95 immunolabeling
intensity in cLH rats is not region specific. In contrast to infra-
limbicmeasurements, the numerical density of PSD95 contacts
in parietal fields did not differ between control and cNLH rats.
Counts of GABAAR
 elements did not differ between parietal
fields in control rats and the two outbred lines.
Discussion
The present studies constitute a first test for differences in gluta-
matergic synapses between related rat strains and between corti-
cal regions within a strain using fluorescence deconvolution
tomography. This automated method counts and measures vol-
umes and labeling intensities of synapses within large fields and
thus can generate sample sizes (e.g.,30,000 PSD95 contacts
per field) needed to detect subtle differences (Rex et al., 2009;
Seese et al., 2012).
Because we surveyed only a proportion of the total layer I
infralimbic cortex, we first performed stringent tests for hetero-
geneity in our sample fields that could introduce significant sam-
pling biases (Dorph-Petersen and Lewis, 2011). Tests of data
directionality and object numerical density within systematically
segregated segments along the sample field did not uncover any
evidence for heterogeneity. Nonetheless, the analyses we present
here in a defined subcomponent of infralimbic cortex cannot be
assumed to hold for the entire cytoarchitectonic field.
We subsequently used fluorescence deconvolution tomogra-
phy to test whether components of excitatory transmission are
disturbed in the congenital learned helplessnessmodel of depres-
sion. Numerous studies support a “glutamate hypothesis” for
chronic depression, but evidence at the level of individual syn-
apses is lacking (Sanacora et al., 2004, 2012; Sartorius et al., 2007;
Yu¨ksel and Ongu¨r, 2010; Hascup et al., 2011). Our results indi-
cate that the density of synapse-sized clusters of PSD95 is reduced
in layer I sample fields of infralimbic cortex, a region associated
with depression, as well as within parietal neocortex of cLH rats.
PSD95 anchors AMPA receptors and signaling proteins to the
PSD (Kim and Sheng, 2004). Thus, changes in synaptic PSD95
concentrations could affect the functional properties of these
connections. In accord with this, the numerical density of
synapse-sized clusters of the AMPA receptor subunit GluA1 was
reduced in cLH rats (Table 1). Because controls and cLH rats
exhibited comparable numerical density of PSD95 synapses,
the reduced GluA1 elements suggest that PSD95 contacts
have AMPA receptors with an abnormal subunit composition.
Alternatively, the GluA1 results may be representative of other
AMPA receptor subunits, in which case the cLH phenotype
would include a sizable population of weak or silent synapses
(Kerchner and Nicoll, 2008). Analyses of other AMPA receptor
subunits should distinguish between these two versions of a “de-
fective synapse” hypothesis. Independent of the exact mecha-
nism, that multiple measurements of many markers show
different group-specific effects strengthens the validity of our re-
sults while providing assurance that differential tissue shrinkage
did not contribute significant biases in our analyses. One would
predict that evidence of differential shrinkage would manifest as
directionally consistent changes in markers tested.
In contrast to effects on excitatory synapses, we did not find
differences in the incidence or immunofluorescence intensity of
GABAergic (i.e., GABAAR
) contacts between cLH and cNLH
rats. GABAergic systems are disturbed in affective disorders:
fewer GABAergic neurons are found in anterior cingulate cortex
in tissue from bipolar patients compared with controls, and an-
tidepressants reverse a GABA deficit in models of depression
(Brambilla et al., 2003). It remains possible that GABAergic in-
nervation differs between groups in layers other than layer I.
PSD95 organizes synaptic elements crucial for synaptic plas-
ticity and memory (Kim and Sheng, 2004). Therefore, reduced
PSD95 levels could impair the ability of synapses to adjust to
changing circumstances and to influence infralimbic networks
involved in emotional behavior. Additional studies are needed to
determine whether aversive stimuli expected to exacerbate mood
symptoms influence infralimbic PSD95 levels in the cLH rats,
especially in light of recent evidence that stress increases hip-
pocampal PSD95 in the Flinders model of depression (Wegener
et al., 2010). PSD95 also interacts with the serotonin 2A receptor
(Xia et al., 2003), a target of antidepressants and whose concen-
tration is abnormal in cortex of depressed patients (Celada et al.,
2004; Shelton et al., 2009). Although it is unlikely that the sparse
population of serotonergic synapses contributed significantly to
results described here, subnormal levels of PSD95 might also be
present at biogenic amine connections. Thus, reductions in
PSD95 could be an originating locus for different components of
affective disorders.
It is unclear why depression would disturb glutamatergic syn-
apses in the manner described here. Astroglial sequestration of
extracellular glutamate is reduced in cLH rats (Zink et al., 2010),
an effect that would lead to extended glutamate receptor activa-
tion after high-frequency afferent activity. Given the intimate
relationship between glutamate receptors and synaptic organiza-
tion, prolonged stimulation could result in reduced concentra-
tions of PSD95 and GluA1. As noted, decreased levels of PSD95
and NMDA receptor subunits have been reported in frontal cor-
tex of patients with MDD (Feyissa et al., 2009). This raises the
possibility that the synaptic disturbances described here provide
conserved biomarkers that might be used in evaluating experi-
mental treatments for aberrant mood control.
We assessed fields in layer I primarily because of its relative
sparsity of cell bodies. Although additional studies are needed to
test whether the observed effects occur in deeper layers, it should
be noted that infralimbic cortex layer I receives afferents from
midline thalamic structures (Vertes and Hoover, 2008), includ-
ing the paratenial nucleus, which in turn are innervated by the
suprachiasmatic nucleus of the hypothalamus (Morin et al.,
1994), a “clock” structure strongly implicated in mood control
(McClung, 2011). The central locus of layer I in this circuit sug-
gests that it is an appropriate site for testing for synaptic abnor-
malities in a model of depression.
It is worth considering the degree to which protein markers,
such as PSD95 and GABAAR, can be used as proxies for synapses
Table 1. Summary of synaptic changes relative to control Sprague Dawley rats
cLH cNLH
Infralimbic cortex
PSD95 C7 V2 I22a C11a V2 I7
GluR1 C2a V7 I7 C7 V7 I7
GABAAR C2 V7 I7 C2 V7 I7
Parietal cortex
PSD95 C7 V7 I2a C7 V7 I7
C, Counts; V, median volume; I, median intensity. Arrows represent relative difference between each strain and
control rats; horizontal arrows represent no difference. One arrow, p 0.05; two arrows, p 0.001.
aKey findings of the study.
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in morphometric studies and whether extrasynaptic receptors
might contribute to analyses using the present techniques. Previ-
ous transmission electron microscopic work has shown that
PSD95 clusters are concentrated exclusively at asymmetric syn-
apses and are present at the majority of those synapses (Aoki et
al., 2001; Sassoe´-Pognetto et al., 2003). Similarly freeze-fracture
immunogold electronmicroscopy has confirmed thatGABAAR

clusters are localized to synapses and correspond strongly to the
size of those synapses, and that the extrasynaptic membrane ex-
hibits only low-density GABAAR immunolabeling (Kasugai et al.,
2010). Thus, extrasynaptic labeling would not be expected to
contribute tomeasures of PSD95 or GABAAR
 elements in the
present work. However it is likely that, because of factors such as
incomplete tissue penetration by antibodies, our analyses under-
estimate numbers of layer I synapses. Comparisons of synapse
counts derived from fluorescence deconvolution tomography to
previous electron microscopic studies of hippocampal field CA1
stratum radiatum suggest that PSD95 immunofluorescence de-
tects 40% of the structurally identified asymmetric synapses
within a given 3D sample field (Fiala andHarris, 2001;Chen et al.,
2007). Unfortunately, we do not have appropriate numerical val-
ues to approximate the proportion of GABAAR-containing syn-
apses detected here. Nevertheless, because the present studies
evaluated tissue from all groups processed identically and to-
gether and because of the relative homogeneity of PSD95 immu-
nolabeling observed in layer I across all groups (Fig. 1), this
underestimation is not likely to influence the effects of strain
observed here.
The breeding program that led to the cLH line also produced
cNLH rats that are resistant to learned helplessness relative to
control rats (Schulz et al., 2010). The cNLH animals did not
exhibit the loss of PSD95 or GluA1 in cortical fields in cLH rats
but instead an increased numerical density of PSD95 clusters.
This effect was not accompanied by an increase in synaptophy-
sin presynaptic elements, indicating that the added PSD95
clusters reflect either large numbers of non-innervated PSDs or
PSD95 synapse-sized clusters in extrasynaptic space. Either
way, resistance to depression is associated with an increase in
“synapse-ready” elements. These results are intriguing in light of
evidence that ketamine, a drug that induces BDNF (Autry et al.,
2011), provides relief in many depressed subjects (Bunney and
Bunney, 2012) and triggers spine formation in frontal cortex of
adult rats (Li et al., 2010). Nonetheless, the resistance to learned
helplessness in cNLH rats may chronically reflect similar mecha-
nisms as those induced by antidepressants.
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